Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE

NCT01984788 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: BCX4161
DRUG: Placebo

Sponsor

BioCryst Pharmaceuticals